Relpax and Duragesic-100 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Duragesic-100 (fentanyl). Common drug interactions include depression among females.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Duragesic-100. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Duragesic-100?

Duragesic-100 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 19,509 Duragesic-100 users. Check the latest studies of Duragesic-100.



On Jul, 12, 2026

16 people who take Relpax and Duragesic-100 together, and have interactions are studied.

Relpax and Duragesic-100 drug interactions.

What are the common drug interactions of Relpax and Duragesic-100, by gender? *:

female:

  1. Depression
  2. Restless legs syndrome (a powerful urge to move your legs)
  3. Blood cholesterol increased
  4. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  5. Mood swings (an extreme or rapid change in mood)
  6. Bladder pain
  7. Bladder spasm
  8. Cystitis (inflammation of the wall of the bladder)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Neuralgia (pain in one or more nerves)

male:

n/a

What are the common drug interactions of Relpax and Duragesic-100, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Thrombosis (formation of a blood clot inside a blood vessel)

30-39:

  1. Application site dermatitis
  2. Application site erythema (redness of the skin at application site)
  3. Dehydration (dryness resulting from the removal of water)
  4. Headache (pain in head)
  5. Nausea (feeling of having an urge to vomit)
  6. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  7. Vomiting

40-49:

  1. Aphagia (inability or refusal to swallow)
  2. Irritability
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Hypersomnia (excessive daytime sleepiness (eds))
  5. Sinusitis (inflammation of sinus)

50-59:

  1. Bladder disorder
  2. Bladder pain
  3. Abdominal discomfort
  4. Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
  5. Breast disorder
  6. Dental caries
  7. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  8. Eating disorder
  9. Fibromyalgia (a long-term condition which causes pain all over the body)
  10. Fluid intake reduced

60+:

n/a

What are the existing conditions these people have? *

  1. Stress And Anxiety: 9 people, 56.25%
  2. Muscle Spasms (muscle contraction): 7 people, 43.75%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 37.50%
  4. High Blood Cholesterol: 6 people, 37.50%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 37.50%
  6. Breakthrough Pain: 6 people, 37.50%
  7. Nausea (feeling of having an urge to vomit): 4 people, 25.00%
  8. Back Pain: 3 people, 18.75%
  9. Fatigue (feeling of tiredness): 3 people, 18.75%
  10. Depression: 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Duragesic-100?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Relpax and Duragesic-100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Duragesic-100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relpax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duragesic-100 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide and fentanyl (the active ingredients of Relpax and Duragesic-100, respectively), and Relpax and Duragesic-100 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: